Jakafi 5 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DX25F6ADC
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $72,881
Award facts
- Contract value 100% obligated
- $72,880.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $72,880.74 on August 13, 2025, for the supply of Jakafi 5 mg tablets (60-count units). The award was issued by the Defense Logistics Agency's Medical Supply Chain division without a set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, which is valued at $499,999,999 and remains valid through November 2026, enabling the agency to procure a comprehensive range of pharmaceutical products to support military health facilities nationwide.
The contract represents a continuation of DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain. The company has demonstrated consistent success in securing delivery orders for prescription medications, biologics, and medical consumables across various therapeutic categories. Jakafi (ruxolitinib), a prescription medication used primarily for myelofibrosis and other conditions, will be delivered to the Park Ridge, Illinois location with an ultimate completion date of August 14, 2025. This award underscores the contractor's capability to provide timely pharmaceutical distribution directly to Department of Defense healthcare facilities.
Quick answers
Who was awarded contract SPE2DX25F6ADC?
SPE2DX25F6ADC was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 13, 2025.
How much is contract SPE2DX25F6ADC worth?
The government has obligated $72,881 on SPE2DX25F6ADC.
Is contract SPE2DX25F6ADC an order under another contract?
Yes. SPE2DX25F6ADC is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6ADC competed?
The extent of competition for SPE2DX25F6ADC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award